Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Borroni

Showing results (41-50 of 507) with videos related to

Pageof 51
Sort By:
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|December 10, 2009
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modelingBarbara Borroni, Mario Grassi, Chiara Costanzi, et al.
Neuroscience Letters|June 19, 2007
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlationsAlessandro Padovani, Chiara Agosti, Enrico Premi, et al.
International Psychogeriatrics|March 28, 2009
Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsyBarbara Borroni, Antonella Alberici, Chiara Agosti, et al.
Neuropsychology|August 7, 2018
Multimodal face and voice recognition disorders in a case with unilateral right anterior temporal lobe atrophyMaura Cosseddu, Stefano Gazzina, Barbara Borroni, et al.
Neurobiology of Disease|February 15, 2025
Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neuronsMaria Italia, Alessio Spinola, Barbara Borroni, et al.
Current Medicinal Chemistry|May 17, 2011
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau diseaseBarbara Borroni, Chiara Agosti, Enrico Magnani, et al.
Neurobiology of Aging|May 10, 2011
Reply to "Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?"Barbara Borroni, Fabrizio Gardoni, Matteo Malinverno, et al.
Journal of the American Geriatrics Society|February 1, 2003
A case report: doctor, my daughter has Alzheimer's diseaseLuca Rozzini, Barbara Borroni, Barbara Vicini Chilovi, et al.
Expert Opinion on Therapeutic Targets|September 30, 2017
ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's diseaseElena Marcello, Barbara Borroni, Silvia Pelucchi, et al.
Neurobiology of Disease|April 20, 2005
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patientsMartina Zimmermann, Barbara Borroni, Flaminio Cattabeni, et al.
Pageof 51

Showing results (41-50 of 507) with videos related to

Sort By:
Pageof 51
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|December 10, 2009
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modelingBarbara Borroni, Mario Grassi, Chiara Costanzi, et al.
Neuroscience Letters|June 19, 2007
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlationsAlessandro Padovani, Chiara Agosti, Enrico Premi, et al.
International Psychogeriatrics|March 28, 2009
Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsyBarbara Borroni, Antonella Alberici, Chiara Agosti, et al.
Neuropsychology|August 7, 2018
Multimodal face and voice recognition disorders in a case with unilateral right anterior temporal lobe atrophyMaura Cosseddu, Stefano Gazzina, Barbara Borroni, et al.
Neurobiology of Disease|February 15, 2025
Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neuronsMaria Italia, Alessio Spinola, Barbara Borroni, et al.
Current Medicinal Chemistry|May 17, 2011
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau diseaseBarbara Borroni, Chiara Agosti, Enrico Magnani, et al.
Neurobiology of Aging|May 10, 2011
Reply to "Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?"Barbara Borroni, Fabrizio Gardoni, Matteo Malinverno, et al.
Journal of the American Geriatrics Society|February 1, 2003
A case report: doctor, my daughter has Alzheimer's diseaseLuca Rozzini, Barbara Borroni, Barbara Vicini Chilovi, et al.
Expert Opinion on Therapeutic Targets|September 30, 2017
ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's diseaseElena Marcello, Barbara Borroni, Silvia Pelucchi, et al.
Neurobiology of Disease|April 20, 2005
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patientsMartina Zimmermann, Barbara Borroni, Flaminio Cattabeni, et al.
Pageof 51